Arthritis psoriatica: vizsgálatok itt: Spanyolország
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleCarotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Where
- Barcelona, Bilbao, Ciudad Real, Córdoba, Elche, Las Palmas De Gran Canaria, Madrid, Murcia, Orihuela, Palma, San Cristóbal de La Laguna, Santander, Sant Joan d'Alacant, Torrelavega, Vitoria, Hospital laredo
- Életkor
- 50 év and over
- People
- 1944
- Run by
- Instituto de Investigación Marqués de Valdecilla
See details and how to joinNCT07611747 · EU 2025-521086-28-00 - 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Bilbao, Madrid, Sabadell, Santiago de Compostela, Sevilla, Valencia
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 3. fázisTaking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Esplugues de Llobregat, Madrid, Seville, Valencia
- Életkor
- 1 év to 18 év
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - 3. fázisTaking peopleA Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Where
- Madrid, Valencia
- Életkor
- 5 év to 18 év
- People
- 48 worldwide
- Run by
- Amgen
See details and how to joinNCT05767047 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Santiago de Compostela, Valencia
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 2 év to 18 év
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - 3. fázisTaking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Barcelona, Esplugues De Llobregat, La Laguna, Madrid, Valencia
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - 3. fázisTaking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Badajoz, Málaga, Sabadell, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 1088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - 3. fázisTaking peopleA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00 - 1. fázisTaking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Alcobendas, Badajoz, Madrid, Málaga, Sabadell, San Cristóbal de La Laguna, Santander, Santiago de Compostela, Sevilla, Valencia, Vitoria
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Esplugues De Llobregat, Valencia
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - 2. fázisNot yet taking people in SpanyolországTesting the safety and efficacy of combining biologic drugs in Rheumatoid and Psoriatic Arthritis
- Where
- Badalona, Barcelona
- Életkor
- 18 év and over
- People
- 10
- Run by
- Cardiff University
See details and how to join2024-518011-19-01 · EU 2024-518011-19-01 - 3. fázisNot yet taking people in SpanyolországA study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- A Coruña, Alcobendas, Bilbao, Castello De La Plana, Madrid, Málaga, Sabadell, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 · EU 2025-522471-28-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Granada, Huelva, Lorca, Madrid, Málaga, Murcia, Seville, Vigo
- Életkor
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693